Company news
Qtrex Quantum Ltd. (NASDAQ:QTEX) news
Qtrex Quantum Ltd. news releases on 6ix. Latest, Dec 27, 2022: Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
Press releases — page 4
Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
December 26, 2022
Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, ahead of planned 2023 FDA submission
December 19, 2022
Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor
December 13, 2022
Inspira™ Technologies Reports Third Quarter 2022 Financial Results
November 22, 2022
InspiraTM Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRATM ART System
November 9, 2022
Inspira™ Technologies Performed HYLA™ Blood Sensor In-Vivo Study, in Preparation of Planned Human Studies
September 6, 2022
Inspira™ Technologies Reports Second Quarter 2022 Financial Results
August 10, 2022
Inspira™ Technologies Reveals Next Generation Liby™ System, an Extracorporeal Membrane Oxygenation System, Targeting a $531 Million Global ECMO Market
July 10, 2022
Inspira™ Technologies Signs Strategic Agreement in U.S. to potentially provide $59 million for Inspira for deployment of 3,889 HYLA™ Blood Sensors
July 6, 2022
Inspira™ Technologies Develops a Non-Invasive Blood Sensor Designed to Alert Real-Time Change in Patients - Potentially Targets $2.5 Billion ABG Market
July 5, 2022
Inspira™ Technologies Announces First Quarter 2022 Financial Results
May 18, 2022
Inspira Technologies Announces Deployment Agreement in the Israeli Market to Target $15M
April 5, 2022
Inspira Technologies Releases Q4 & FY2021 Financial Results
March 30, 2022
Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO) - Daniella Yeheskely-Hayon PhD
February 2, 2022
Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals
January 30, 2022
Inspira Technologies Signs Strategic Agreement with Innovimed for the Potential Deployment of 1,522 ART Systems in Poland, Czech Republic & Slovakia
December 8, 2021
Inspira Technologies Files a PCT Patent Application for its Flagship ART Device and Proprietary Method of Use to Minimize the Need for Mechanical Ventilation
December 7, 2021
Inspira Technologies: Professor Eddy Fan, Expert in Critical Care Medicine and Extracorporeal Support, Joins Inspira's Scientific Advisory Board
November 29, 2021
Inspira Technologies Announces 2021 Third Quarter Financial Results
November 22, 2021
Inspira Technologies Files a PCT Patent Application for its Novel Dual Lumen Cannula Used for Blood Oxygenation
November 9, 2021
Inspira Technologies Enters Europe: Signs a Strategic Agreement With Waas Group for the Deployment of 1,040 ART Systems in Spain and Portugal
October 25, 2021
Inspira Technologies Files a Patent Application for a Supportive Device to be Utilized with the ART Device
September 14, 2021
Inspira Technologies Reached Important Milestone as It Completed a Pump Bench Study
August 17, 2021
Inspira Technologies Announces First Half 2021 Financial Results and Provides Business Update
August 12, 2021
Inspira Technologies Expands Board of Directors to Accelerate Company's Go-to-Market Efforts
August 9, 2021
Inspira Expands Medical Advisory Board as Part of Future Expansion into North American Market
July 25, 2021
Inspira Technologies OXY B.H.N. Ltd Announces Closing of Initial Public Offering
July 15, 2021
Inspira Technologies OXY B.H.N. Ltd Announces Pricing of Initial Public Offering
July 12, 2021